Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients-Reference-Cited by-同舟云学术

Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients

Published:2005-01 Issue:1 Volume:15 Page:1-5
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:Pharmacogenetics and Genomics

Author:

Rotger Margalida,Colombo Sara,Furrer Hansjakob,Bleiber Gabriela,Buclin Thierry,Lee Belle L.,Keiser Olivia,Biollaz Jérôme,Décosterd Laurent,Telenti Amalio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference19 articles.

1. Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection

2. The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity

3. Constitutive Androstane Receptor and Pregnane X Receptor Gene Expression in Human Liver: Interindividual Variability and Correlation with CYP2B6 mRNA Levels

Cited by 320 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Physiologically-Based Pharmacokinetic Simulation to Evaluate Approaches to Mitigate Efavirenz-Induced Decrease in Levonorgestrel Exposure with a Contraceptive Implant;Pharmaceutics;2024-08-07

2. Oral Administration of Efavirenz Dysregulates the Tph2 Gene in Brain Serotonergic Areas and Alters Weight and Mood in Mice;Pharmaceuticals;2024-06-18

3. Pharmacogenetics of Efavirenz Exposure in Cervicovaginal Fluid during Pregnancy and Postpartum;Clinical Pharmacology & Therapeutics;2024-06-10

4. Genetic Polymorphisms in CYP2 Gene Family in Bulgarian Individuals and their Clinical Implications;Acta Medica Bulgarica;2024-03-01

5. A Bayesian approach for investigating the pharmacogenetics of combination antiretroviral therapy in people with HIV;Biostatistics;2024-02-14